Publications
- A Comparison of the Neuroprotective and Reactivating Efficacy of a Novel Bispyridinium Oxime K870 with Commonly Used Pralidoxime and the Oxime HI-6 in Tabun-Poisoned Rats2021 | Publication without faculty affiliation
- The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats2018 | Publication without faculty affiliation
- The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K2032017 | Publication without faculty affiliation
- HI-6 treatment does not reactivate sarin inhibited acetylcholinesterase activity in dog brain when administered in human therapeutical dose 30 minutes after the poisoning2016 | Faculty of Medicine in Hradec Králové
- The ability of oxime mixtures to increase the reactivating and therapeutic efficacy of antidotal treatment of cyclosarin poisoning in rats and mice2012 | Faculty of Medicine in Hradec Králové
- The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice2011 | Faculty of Medicine in Hradec Králové
- A comparison of the reactivating and therapeutic efficacy of chosen combinations of oximes with individual oximes against VX in rats and mice2011 | Faculty of Medicine in Hradec Králové
- The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice2010 | Faculty of Medicine in Hradec Králové
- A comparison of reactivation and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice2010 | Faculty of Medicine in Hradec Králové
- A comparison of efficacy of the acetylcholinesterase modulators in dogs using quantitative histochemistry2010 | Faculty of Medicine in Hradec Králové
Loading network view...